Mercer Global Advisors »

Kiniksa Pharmaceuticals shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $329k 19k 17.51
2023-09-30 $298k 17k 17.37
2023-06-30 $327k 23k 14.08
2023-03-31 $195k 18k 10.73

More positions owned by Mercer Global Advisors

Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Apple (AAPL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Intl Ftse Dev M (VEA)
Vanguard Charlotte Fds Intl Bd Idx Etf (BNDX)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us High Profitab (DUHP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Msci Intl Moment (IMTM)

View all positions for Mercer Global Advisors

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals